EC0225: Clinical Trials

1 trial of EC0225, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow EC0225: new trials by email Literature Review of EC0225 trials Research Report on EC0225

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of EC0225 for the Treatment of Refractory or Metastatic Tumors
EC0225, for Injection (Folic acid desacetylvinblastine hydrazide conjugate), 99mTC-EC20 (Folic acid-technetium 99m conjugate) - Cancer
Phase 1CompletedEndocyte772007-02-012012-03-09

Conditions studied

Neoplasm Metastasis (1)  ·  Neoplasms (1)

Sponsors

Endocyte (1)

Countries

United States (1)

Top investigators

Richard A. Messmann, MD, MHS, MSc (1)